| 20506-2 |
Specimen drawn from |
Type |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Specimen drawn from |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
20506-2 |
|
|
|
|
Observation |
|
|
|
0 |
Specimen drawn from Patient |
|
|
|
|
|
Nominal; Point in time; Random; Spec; Typ |
2.73 |
1.0m |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 20507-0 |
Reagin Ab |
PrThr |
Ser |
Pt |
Ord |
RPR |
|
ACTIVE |
Reagin Ab [Presence] in Serum by RPR |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20507-0 |
|
RPR |
|
|
Both |
|
|
|
0 |
RPR Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Charcoal flocculation; ID; Infectious Disease; InfectiousDisease; Microbiology; Neurosyphilis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rapid plasma reagin; Screen; Serum; SR; Syphilis; Treponema; UniversalLabOrders |
2.73 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
215 |
| 20508-8 |
Reagin Ab |
ACnc |
Ser/Plas |
Pt |
Qn |
RPR |
|
ACTIVE |
Reagin Ab [Units/volume] in Serum or Plasma by RPR |
|
MIN |
DefinitionDescription |
|
|
Dils |
|
|
|
|
|
|
MICRO |
|
20508-8 |
|
RPR |
|
|
Both |
|
|
|
0 |
RPR SerPl-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Charcoal flocculation; ID; Infectious Disease; InfectiousDisease; Microbiology; Neurosyphilis; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rapid plasma reagin; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Syphilis; Treponema |
2.73 |
1.0m |
|
|
|
|
|
|
|
{dils} |
|
|
Release 2.70: SYSTEM: Updated System from "Ser" because this test can be done on serum or plasma; |
0 |
| 20509-6 |
Hemoglobin |
MCnc |
Bld |
Pt |
Qn |
Calculated |
|
ACTIVE |
Hemoglobin [Mass/volume] in Blood by calculation |
|
MIN |
DefinitionDescription |
|
|
g/dL |
|
|
hemoglobin (g/dL) = hematocrit (% PCV) x 0.34 |
|
|
|
HEM/BC |
|
20509-6 |
|
Calculated |
|
|
Observation |
|
|
|
0 |
Hgb Bld Calc-mCnc |
|
|
|
Y |
|
Blood; Calc; Calculation; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0m |
|
|
|
|
|
|
|
g/dL |
|
|
|
0 |
| 2051-1 |
Carnosine |
MCnc |
Urine |
Pt |
Qn |
|
|
DISCOURAGED |
Carnosine [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
2051-1 |
|
|
|
|
Observation |
|
|
|
0 |
Carnosine Ur-mCnc |
|
|
|
Y |
|
Car; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.44 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 20510-4 |
Lipoprotein pattern |
Imp |
Ser/Plas |
Pt |
Nom |
Electrophoresis |
|
ACTIVE |
Lipoprotein fractions [Interpretation] in Serum or Plasma by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
20510-4 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
LP SerPl Elph-Imp |
|
|
|
|
|
Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lip; Lipoprot; Lipoproteins; LP; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0m |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 20511-2 |
Creatinine |
Imp |
Urine |
Pt |
Nom |
|
|
ACTIVE |
Creatinine [Interpretation] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
20511-2 |
|
|
|
|
Observation |
|
|
|
0 |
Creat Ur-Imp |
|
|
|
|
|
Chemistry; CR; Crea; Creat; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Kidney; Nephrology; Nominal; Point in time; Random; Renal; UA; UCr; UR; Urn |
2.26 |
1.0m |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 20512-0 |
Turbidity |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Turbidity [Presence] of Cerebral spinal fluid Qualitative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
20512-0 |
|
|
|
|
Observation |
|
|
|
0 |
Turbidity CSF Ql |
|
|
|
|
|
Cerebral spinal fluid; Cerebrospinal Fl; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SPEC; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.73 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20513-8 |
Turbidity |
PrThr |
Body fld |
Pt |
Ord |
|
|
ACTIVE |
Turbidity [Presence] of Body fluid Qualitative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
20513-8 |
|
|
|
|
Observation |
|
|
|
0 |
Turbidity Fld Ql |
|
|
|
|
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SPEC |
2.73 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20514-6 |
6-Monoacetylmorphine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
DEPRECATED |
Deprecated 6-Monoacetylmorphine [Mass/volume] in Urine Confirm |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
20514-6 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Deprecated 6MAM Ur Cfm-mCnc |
|
|
|
Y |
|
6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Heroin metabolite; Illicit; LC/MS/MS; Level; MAM; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.4 |
1.0m |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 20515-3 |
Amitriptyline |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Amitriptyline [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20515-3 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Amitrip Ur Cfm-mCnc |
|
|
|
Y |
|
Amit; Amitrip; Amitriptylene; Amitriptyln; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Elatrol; Elavil; Endep; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Trepiline; Tryptanol; Tryptizol; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20516-1 |
Amitriptyline+Nortriptyline |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Amitriptyline+Nortriptyline [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20516-1 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Amitrip+Nor Ur Cfm-mCnc |
|
|
|
Y |
|
Amit; Amitrip; Amitrip+Nor; Amitriptylene; Amitriptyline metabolite; Amitriptyln; Aventyl; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Elatrol; Elavil; Endep; GCMS; LC/MS/MS; Level; Mass concentration; Nortrip; Nortriptylene; Nortriptyln; Pamelor; Point in time; QNT; Quan; Quant; Quantitative; Random; Trepiline; Tryptanol; Tryptizol; UA; UR; Urn |
2.42 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20517-9 |
Aprobarbital |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Aprobarbital [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20517-9 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Aprobarbital Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Oramon; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 20518-7 |
Barbital |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Barbital [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20518-7 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Barbital Ur Cfm-mCnc |
|
|
|
Y |
|
Addiction; Barbitone; Barbiturate; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diethylmalonylurea; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Megal; Neurinase; Pneumogeine-barbital; Point in time; PotentialForAbuse; Provervon n; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Veraine buriat; Veronal; Vitanerton N Kerne |
2.36 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20519-5 |
Cocaine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Cocaine [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20519-5 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Cocaine Ur Cfm-mCnc |
|
|
|
Y |
|
Addiction; Benzoylmethylecgonine; Cfm; CNFR; CNFRM; Coke; Conf; Confirmation; Confirmatory; Crack; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Snow; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 2052-9 |
Carotene |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Carotene [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/dL |
|
|
|
|
|
|
CHEM |
|
2052-9 |
|
|
|
|
Both |
|
|
|
0 |
Carotene Bld-mCnc |
|
|
|
Y |
|
Beta carotene; Blood; Chemistry; Level; Mass concentration; Point in time; Pro vitamin A; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.4 |
1 |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
| 20520-3 |
Bromazepam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Bromazepam [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20520-3 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Bromazepam Ur Cfm-mCnc |
|
|
|
Y |
|
Bromazanil; Brozam; Calmepam; Cfm; CNFR; CNFRM; Compendium; Conf; Confirmation; Confirmatory; Creosedin; DRUG/TOXICOLOGY; Drugs; Durazanil; GCMS; Gityl; LC/MS/MS; Lectopam; Level; Lexatin; Lexaurin; Lexonil; Lexotan; Lexotanil; Mass concentration; Neo-opt; Normoc; Point in time; QNT; Quan; Quant; Quantitative; Random; Somalium; UA; UR; Urn |
2.42 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20521-1 |
Carboxy tetrahydrocannabinol |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Carboxy tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20521-1 |
|
Confirm |
|
|
Both |
|
|
|
0 |
CarboxyTHC Ur Cfm-mCnc |
|
|
|
Y |
|
11-nor-9-carboxy-delta-9-THC; 11-nor-9-carboxy-THC; 11-nor-delta-9-THC-9-COOH; 9-carboxy-11-nor-delta-9-tetrahydrocannabinol; Addiction; Carboxytetrahydrocannabinol; CarboxyTHC; Carboxy-THC-delta-9; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Delta-9-tetrahydrocannabinol metabolite; Dronabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Marijuana; Mass concentration; Nabilone; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; THC; THCA; THCC; THCCOOH; THC-COOH; UA; UniversalLabOrders; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20522-9 |
chlordiazePOXIDE |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
chlordiazePOXIDE [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20522-9 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Chlordiazep Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; Chlordiaz; Chlordiaze; Chlordiazep; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Librium; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 20523-7 |
chlorproMAZINE |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
chlorproMAZINE [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20523-7 |
|
Confirm |
|
|
Both |
|
|
|
0 |
chlorproMAZINE Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; Chlopromazine; Chlorpromaz; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Thorazine; UA; UR; Urn |
2.42 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20524-5 |
Tetrahydrocannabinol |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
DEPRECATED |
Deprecated Tetrahydrocannabinol [Mass/volume] in Urine by Confirm method |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
20524-5 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Deprecated THC Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Dronabinol; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Marijuana; Mass concentration; Nabilone; Point in time; QNT; Quan; Quant; Quantitative; Random; THC; UA; UR; Urn |
2.36 |
1.0m |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 20525-2 |
Dextroamphetamine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Dextroamphetamine [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20525-2 |
|
Confirm |
|
|
Both |
|
|
|
0 |
D-amphet Ur Cfm-mCnc |
|
|
|
Y |
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; D-amphet; D-amphetamine; Dexedrine; Dextro-amphetamine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20526-0 |
Dimetamphetamine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Dimetamphetamine [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20526-0 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Dimetamphet Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dimethamphetimine; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20527-8 |
Ethylmorphine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Ethylmorphine [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20527-8 |
|
Confirm |
|
|
Both |
|
|
|
0 |
EMP Ur Cfm-mCnc |
|
|
|
Y |
|
Addiction; Cfm; CNFR; CNFRM; Codethyline; Collins elixir; Conf; Confirmation; Confirmatory; Dionina; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; EMP; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20528-6 |
Flunitrazepam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Flunitrazepam [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20528-6 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Flunitrazepam Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Darkene; DRUG/TOXICOLOGY; Drugs; GCMS; Hypnodorm; Hypnor; LC/MS/MS; Level; Mass concentration; Narcozep; Noriel; Point in time; QNT; Quan; Quant; Quantitative; Random; Rohipnol; Rohypnol; Roipnol; UA; UR; Urn; Valsera |
2.73 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
